Project Grant DP2CA290244
Award Date
9/19/23
Completion Date
8/31/26
Dollars Obligated
$1.5M
Funding Federal Agency
Office of the Director
Awarding Federal Agency
National Cancer Institute
Federal Grant Program
93.310
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94143, USA
Similar Awards
This $616,786 Project Grant was awarded on June 1, 2025 by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The award will support research conducted by The Regents of the University of California, San Francisco (UCSF) to uncover the evolutionary mechanisms driving phenotypic variation in human populations. Key areas of investigation include the effects of recessive deleterious alleles and associative...
This federal Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) provides $552,874 in funding to The Regents of the University of California, San Francisco (UCSF) for a 5-year period from Aug 1, 2024 to Jul 31, 2029. The grant will support research to precisely dissect the cellular and molecular pathways by which the A20 protein regulates anti-tumor immunity. The goal is to gain a better understanding of how tumors persist and grow within tissues by...
This $550,255 five-year Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) supports research to advance the "Structural Surfaceomics" technology at the University of California, San Francisco (UCSF). The key objectives are: Further developing the technical and analytical aspects of the Structural Surfaceomics platform to enable broader identification of cancer-specific surface protein conformations across different tumor types. This work aims...
The Regents of the University of California, San Francisco (UCSF) received a $284,636 Project Grant award from the National Science Foundation Division of Molecular and Cellular Biosciences under the Biological Sciences (CFDA 47.074) federal grant program. The two-year award will support research establishing novel tools to artificially manipulate chromosome folding and modulate various genome functions, including enhancer regulation of gene expression. Specifically, the grant will fund...
The University of California, San Francisco (UCSF) was awarded a $6,778,819 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on April 1, 2024, will fund a 4-year research project to conduct low-pass whole-genome sequencing to improve breast cancer risk assessment in a diverse population. UCSF will serve as the prime awardee, with the University of Chicago receiving a sub-award to contribute...
This federal Project Grant award of $695,916 from the National Cancer Institute (CFDA 93.395 Cancer Treatment Research) aims to identify and optimize novel inhibitors of the enzyme nSMase2 as a potential therapeutic strategy to overcome resistance to immune checkpoint inhibitors in cancer treatment. The primary awardee, the Regents of the University of California, San Francisco (UCSF), will work to develop and evaluate 1-2 nSMase2 inhibitor "prodrugs" with improved oral...
The University of California, San Francisco (UCSF) has been awarded a $726,750 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). This 3-year federal grant, with a period of performance from June 2024 to June 2027, will support research to elucidate the role of ERα RNA binding activity in breast cancer progression and drug-tolerant persister cells. As a leading academic medical center with extensive experience in federally...
This federal Project Grant award, funded by the National Cancer Institute (NCI) under the Cancer Biology Research program (CFDA 93.396), aims to investigate the biological mechanisms underlying racial disparities in head and neck cancer outcomes, particularly among Black patients. The $714,062 award, with a period of performance from April 2025 to March 2030, will be provided to the University of California, San Francisco (UCSF) to pursue two key objectives: 1) Developing a tailored RNA...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,615,000.00 to The Regents of the University of California, San Francisco (UCSF) to conduct research aimed at "DISCOVERING TRANSCRIPTIONAL DRIVERS OF THERAPY-RESISTANT METASTATIC PROSTATE CANCER". The award period runs from May 1, 2024 to April 30, 2027. As a leading academic medical center, UCSF has a strong track record of...
The University of California, San Francisco (UCSF) received a $4,408,316 Project Grant award from the National Cancer Institute's Cancer Centers Support Grants (CFDA 93.397) program. The award will fund a Specialized Programs of Research Excellence (SPORE) in Prostate Cancer with the overarching goal of reducing the morbidity and mortality associated with prostate cancer through translational research. The grant supports three scientific projects: 1) Combination immunotherapy with radioligand...